average common
shares outstanding:
Basic 38,665 39,444 39,139 39,406
Diluted 38,788 39,555 39,247 39,513
TECHNE CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
ASSETS 6/30/08 6/30/07
Cash and equivalents $166,992 $135,485
Short-term available-for-sale investments 39,353 29,289
Trade accounts receivable 31,747 29,559
Other receivables 1,585 1,407
Inventory 9,515 8,757
Other current assets 9,241 8,341
Current assets 258,433 212,838
Available-for-sale investments 87,384 91,433
Property and equipment, net 101,722 91,535
Goodwill and intangible assets, net 29,032 30,167
Other non-current assets 30,798 28,871
Total assets $507,369 $454,844
LIABILITIES
Current liabilities $20,239 $17,193
Stockholders' equity 487,130 437,651
Total liabilities and equity $507,369 $454,844
'/>"/>SOURCE Techne Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 Related biology technology :1.
Techne Corporation Announces Share Repurchase Authorization2.
Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 20083.
Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue4.
PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation5.
AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II6.
Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)7.
BioElectronics Corporation Announces Singapore and Malaysia Sales8.
Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds9.
DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference10.
Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 200711.
Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference